Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

The European Certificate in Nephrology: towards harmonization and excellence in training.

Cannata-Andía JB, Weinstein T, Slotki I, Ferreira A, Zoccali C, Lappin D; UEMS Renal Section and Boards and ERA-EDTA.

Clin Kidney J. 2018 Oct 22;12(2):167-171. doi: 10.1093/ckj/sfy106. eCollection 2019 Apr.

2.

Vitamin D Receptor Polymorphism and DHCR7 Contribute to the Abnormal Interplay Between Vitamin D and Lipid Profile in Rheumatoid Arthritis.

Rodríguez-Carrio J, Alperi-López M, Naves-Díaz M, Dusso A, López P, Ballina-García FJ, Cannata-Andía JB, Suárez A.

Sci Rep. 2019 Feb 22;9(1):2546. doi: 10.1038/s41598-019-38756-8.

3.

Clinical and subclinical cardiovascular disease in female SLE patients: Interplay between body mass index and bone mineral density.

Rodríguez-Carrio J, Martínez-Zapico A, Cabezas-Rodríguez I, Benavente L, Pérez-Álvarez ÁI, López P, Cannata-Andía JB, Naves-Díaz M, Suárez A.

Nutr Metab Cardiovasc Dis. 2019 Feb;29(2):135-143. doi: 10.1016/j.numecd.2018.09.007. Epub 2018 Oct 15.

PMID:
30559042
4.

Variants in cardiac GATA genes associated with bicuspid aortic valve.

Alonso-Montes C, Martín M, Martínez-Arias L, Coto E, Naves-Díaz M, Morís C, Cannata-Andía JB, Rodríguez I.

Eur J Clin Invest. 2018 Dec;48(12):e13027. doi: 10.1111/eci.13027. Epub 2018 Oct 8.

PMID:
30229885
5.

High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.

Carrillo-López N, Panizo S, Alonso-Montes C, Martínez-Arias L, Avello N, Sosa P, Dusso AS, Cannata-Andía JB, Naves-Díaz M.

Nephrol Dial Transplant. 2019 Jun 1;34(6):934-941. doi: 10.1093/ndt/gfy287.

PMID:
30189026
6.

Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients.

Carrero JJ, Cabezas-Rodríguez I, Qureshi AR, Floege J, Ketteler M, London G, Locatelli F, Memmos D, Goldsmith D, Ferreira A, Nagy J, Teplan V, Martínez-Salgado C, Fernández-Martín JL, Zoccali C, Cannata-Andia JB; COSMOS group.

Nefrologia. 2018 Sep - Oct;38(5):520-527. doi: 10.1016/j.nefro.2018.02.009. Epub 2018 Jun 11. English, Spanish.

7.

Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study.

Fernández-Martín JL, Dusso A, Martínez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G, Locatelli F, Górriz JL, Rutkowski B, Bos WJ, Tielemans C, Martin PY, Wüthrich RP, Pavlovic D, Benedik M, Rodríguez-Puyol D, Carrero JJ, Zoccali C, Cannata-Andía JB; COSMOS group .

Nephrol Dial Transplant. 2019 Apr 1;34(4):673-681. doi: 10.1093/ndt/gfy093.

PMID:
29741651
8.

Bone and mineral metabolism at 55 haemodialysis centres in Lima.

Méndez-Chacón P, Riccobelli N, Dionisi MP, Sánchez-Álvarez E, Bardales-Viguria F, Méndez-Chacón Rodríguez C, Cannata-Andía JB, Fernández-Martín JL.

Nefrologia. 2018 May - Jun;38(3):279-285. doi: 10.1016/j.nefro.2017.09.011. English, Spanish.

9.

Clinical relevance and future perspective of fractures in patients with chronic kidney disease.

Fusaro M, Cannata-Andía JB, Nickolas TL, Plebani M, Mereu MC, Aghi A, Gallieni M.

Kidney Int. 2018 May;93(5):1248. doi: 10.1016/j.kint.2018.02.012. No abstract available.

PMID:
29680025
10.

Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis.

Panizo S, Carrillo-López N, Naves-Díaz M, Solache-Berrocal G, Martínez-Arias L, Rodrigues-Díez RR, Fernández-Vázquez A, Martínez-Salgado C, Ruiz-Ortega M, Dusso A, Cannata-Andía JB, Rodríguez I.

Nephrol Dial Transplant. 2017 Nov 1;32(11):1831-1840. doi: 10.1093/ndt/gfx060.

PMID:
28460073
11.

Rare genetic variants in GATA transcription factors in patients with hypertrophic cardiomyopathy.

Alonso-Montes C, Rodríguez-Reguero J, Martín M, Gómez J, Coto E, Naves-Díaz M, Morís C, Cannata-Andía JB, Rodríguez I.

J Investig Med. 2017 Jun;65(5):926-934. doi: 10.1136/jim-2016-000364. Epub 2017 Apr 5.

PMID:
28381408
12.

Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.

Carrillo-López N, Panizo S, Alonso-Montes C, Román-García P, Rodríguez I, Martínez-Salgado C, Dusso AS, Naves M, Cannata-Andía JB.

Kidney Int. 2016 Jul;90(1):77-89. doi: 10.1016/j.kint.2016.01.024. Epub 2016 Mar 24.

PMID:
27165819
13.

COSMOS Project: Hemodialysis scenario in Europe.

Cannata-Andía JB, Fernández Martín JL.

Nefrologia. 2016 Jul-Aug;36(4):381-8. doi: 10.1016/j.nefro.2016.03.008. Epub 2016 Apr 23. English, Spanish. No abstract available.

14.

What should the characteristics and attributes of an accredited nephrology training programme be? Looking for high standards.

Gleeson PJ, Slotki I, Cannata-Andia JB, Lappin DW.

Clin Kidney J. 2016 Feb;9(1):23-8. doi: 10.1093/ckj/sfv134. Epub 2015 Dec 28.

15.

Lamin A is involved in the development of vascular calcification induced by chronic kidney failure and phosphorus load.

Quirós-González I, Román-García P, Alonso-Montes C, Barrio-Vázquez S, Carrillo-López N, Naves-Díaz M, Mora MI, Corrales FJ, López-Hernández FJ, Ruiz-Torres MP, Cannata-Andía JB, Fernández-Martín JL.

Bone. 2016 Mar;84:160-168. doi: 10.1016/j.bone.2016.01.005. Epub 2016 Jan 6.

PMID:
26769003
16.

The hypercalcaemia of CYP24A1 inactivation: new ways to improve diagnosis and treatment.

Dusso AS, Gomez-Alonso C, Cannata-Andia JB.

Clin Kidney J. 2015 Aug;8(4):456-8. doi: 10.1093/ckj/sfv058. Epub 2015 Jul 6.

17.

Plasma Cardiotrophin-1 as a Marker of Hypertension and Diabetes-Induced Target Organ Damage and Cardiovascular Risk.

Gamella-Pozuelo L, Fuentes-Calvo I, Gómez-Marcos MA, Recio-Rodriguez JI, Agudo-Conde C, Fernández-Martín JL, Cannata-Andía JB, López-Novoa JM, García-Ortiz L, Martínez-Salgado C.

Medicine (Baltimore). 2015 Jul;94(30):e1218. doi: 10.1097/MD.0000000000001218.

18.

MicroRNAs 29b, 133b, and 211 Regulate Vascular Smooth Muscle Calcification Mediated by High Phosphorus.

Panizo S, Naves-Díaz M, Carrillo-López N, Martínez-Arias L, Fernández-Martín JL, Ruiz-Torres MP, Cannata-Andía JB, Rodríguez I.

J Am Soc Nephrol. 2016 Mar;27(3):824-34. doi: 10.1681/ASN.2014050520. Epub 2015 Jul 17.

19.

Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study.

Fernández-Martín JL, Martínez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G, Locatelli F, Gorriz JL, Rutkowski B, Ferreira A, Bos WJ, Covic A, Rodríguez-García M, Sánchez JE, Rodríguez-Puyol D, Cannata-Andia JB; COSMOS group.

Nephrol Dial Transplant. 2015 Sep;30(9):1542-51. doi: 10.1093/ndt/gfv099. Epub 2015 Apr 28.

PMID:
25920921
20.

The challenge of controlling phosphorus in chronic kidney disease.

Cannata-Andía JB, Martin KJ.

Nephrol Dial Transplant. 2016 Apr;31(4):541-7. doi: 10.1093/ndt/gfv055. Epub 2015 Mar 13. Review.

PMID:
25770169
21.

Association of matrix Gla protein gene functional polymorphisms with loss of bone mineral density and progression of aortic calcification.

Tuñón-Le Poultel D, Cannata-Andía JB, Román-García P, Díaz-López JB, Coto E, Gómez C, Naves-Díaz M, Rodríguez I.

Osteoporos Int. 2014 Apr;25(4):1237-46. doi: 10.1007/s00198-013-2577-1. Epub 2013 Nov 27.

PMID:
24281054
22.

Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis.

Panizo S, Barrio-Vázquez S, Naves-Díaz M, Carrillo-López N, Rodríguez I, Fernández-Vázquez A, Valdivielso JM, Thadhani R, Cannata-Andía JB.

Nephrol Dial Transplant. 2013 Nov;28(11):2735-44. doi: 10.1093/ndt/gft268. Epub 2013 Sep 7.

PMID:
24013683
23.

Influence of body mass index on the association of weight changes with mortality in hemodialysis patients.

Cabezas-Rodriguez I, Carrero JJ, Zoccali C, Qureshi AR, Ketteler M, Floege J, London G, Locatelli F, Gorriz JL, Rutkowski B, Memmos D, Ferreira A, Covic A, Teplan V, Bos WJ, Kramar R, Pavlovic D, Goldsmith D, Nagy J, Benedik M, Verbeelen D, Tielemans C, Wüthrich RP, Martin PY, Martínez-Salgado C, Fernández-Martín JL, Cannata-Andia JB.

Clin J Am Soc Nephrol. 2013 Oct;8(10):1725-33. doi: 10.2215/CJN.10951012. Epub 2013 Sep 5.

24.

[Observational studies: the hazard and other gods].

Arenas-Fernández J, Fernández-Martín JL, Cannata-Andía JB, Martínez-Camblor P.

Med Clin (Barc). 2014 Jan 21;142(2):80-4. doi: 10.1016/j.medcli.2013.05.007. Epub 2013 Jul 5. Spanish. No abstract available.

PMID:
23831405
25.

Use of phosphate-binding agents is associated with a lower risk of mortality.

Cannata-Andía JB, Fernández-Martín JL, Locatelli F, London G, Gorriz JL, Floege J, Ketteler M, Ferreira A, Covic A, Rutkowski B, Memmos D, Bos WJ, Teplan V, Nagy J, Tielemans C, Verbeelen D, Goldsmith D, Kramar R, Martin PY, Wüthrich RP, Pavlovic D, Benedik M, Sánchez JE, Martínez-Camblor P, Naves-Díaz M, Carrero JJ, Zoccali C.

Kidney Int. 2013 Nov;84(5):998-1008. doi: 10.1038/ki.2013.185. Epub 2013 Jul 3.

26.

Low transcriptional activity haplotype of matrix metalloproteinase 1 is less frequent in bicuspid aortic valve patients.

Martín M, Pichel IA, Flórez Muñoz JP, Naves-Díaz M, Palacín M, Cannata-Andía JB, Morís C, Rodríguez I.

Gene. 2013 Jul 25;524(2):304-8. doi: 10.1016/j.gene.2013.03.127. Epub 2013 Apr 19.

PMID:
23603351
27.

Aortic stenosis: a complex, atherosclerosis-like, multifactorial disease.

Martín M, Muñoz JP, Pichel IA, Tuñón Le-Poultel D, Cannata-Andía JB, Rodríguez I.

Int J Cardiol. 2013 Oct 3;168(3):2966. doi: 10.1016/j.ijcard.2013.03.109. Epub 2013 Apr 18. No abstract available.

PMID:
23602282
28.

Amadori products promote cellular senescence activating insulin-like growth factor-1 receptor and down-regulating the antioxidant enzyme catalase.

Del Nogal-Ávila M, Troyano-Suárez N, Román-García P, Cannata-Andía JB, Rodriguez-Puyol M, Rodriguez-Puyol D, Kuro-O M, Ruiz-Torres MP.

Int J Biochem Cell Biol. 2013 Jul;45(7):1255-64. doi: 10.1016/j.biocel.2013.03.018. Epub 2013 Apr 8.

PMID:
23579096
29.

Comment on Freemantle et al.: Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments.

Brandi ML, Reginster JY, Rizzoli R, Cannata-Andia JB.

Osteoporos Int. 2013 Jun;24(6):1929-30. doi: 10.1007/s00198-013-2297-6. Epub 2013 Feb 14. No abstract available.

PMID:
23408018
30.

Updated programme for harmonization of training in nephrology in the European Union.

Lappin DW, Cannata-Andia JB; UEMS Section in Nephrology.

Clin Kidney J. 2013 Feb;6(1):116-121. Epub 2013 Jan 4.

31.

COSMOS: the dialysis scenario of CKD-MBD in Europe.

Fernández-Martín JL, Carrero JJ, Benedik M, Bos WJ, Covic A, Ferreira A, Floege J, Goldsmith D, Gorriz JL, Ketteler M, Kramar R, Locatelli F, London G, Martin PY, Memmos D, Nagy J, Naves-Díaz M, Pavlovic D, Rodríguez-García M, Rutkowski B, Teplan V, Tielemans C, Verbeelen D, Wüthrich RP, Martínez-Camblor P, Cabezas-Rodriguez I, Sánchez-Alvarez JE, Cannata-Andia JB.

Nephrol Dial Transplant. 2013 Jul;28(7):1922-35. doi: 10.1093/ndt/gfs418. Epub 2012 Nov 19.

32.

Osteoporosis and adynamic bone in chronic kidney disease.

Cannata-Andía JB, Rodriguez García M, Gómez Alonso C.

J Nephrol. 2013 Jan-Feb;26(1):73-80. doi: 10.5301/jn.5000212. Review.

PMID:
23023723
33.

New polymorphisms in human MEF2C gene as potential modifier of hypertrophic cardiomyopathy.

Alonso-Montes C, Naves-Diaz M, Fernandez-Martin JL, Rodriguez-Reguero J, Moris C, Coto E, Cannata-Andia JB, Rodriguez I.

Mol Biol Rep. 2012 Sep;39(9):8777-85. doi: 10.1007/s11033-012-1740-7. Epub 2012 Jun 21.

PMID:
22718505
34.

Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.

Román-García P, Carrillo-López N, Naves-Díaz M, Rodríguez I, Ortiz A, Cannata-Andía JB.

Endocrinology. 2012 Apr;153(4):1627-37. doi: 10.1210/en.2011-1770. Epub 2012 Feb 14.

PMID:
22334717
35.

The connections between vascular calcification and bone health.

Cannata-Andia JB, Roman-Garcia P, Hruska K.

Nephrol Dial Transplant. 2011 Nov;26(11):3429-36. doi: 10.1093/ndt/gfr591. Review.

36.

Chronic kidney disease--mineral and bone disorder: a complex scenario.

Mejía N, Roman-García P, Miar AB, Tavira B, Cannata-Andía JB.

Nefrologia. 2011;31(5):514-9. doi: 10.3265/Nefrologia.pre2011.Jun.10926. Review. English, Spanish.

37.

Natural antioxidants and vascular calcification: a possible benefit.

Roman-Garcia P, Barrio-Vazquez S, Fernandez-Martin JL, Ruiz-Torres MP, Cannata-Andia JB.

J Nephrol. 2011 Nov-Dec;24(6):669-72. doi: 10.5301/jn.5000029.

PMID:
21928237
38.

Bone: osteoporosis therapy--time to consider renal function.

Cannata-Andía JB, Gómez-Alonso C.

Nat Rev Endocrinol. 2011 Jul 5;7(8):440-1. doi: 10.1038/nrendo.2011.114. No abstract available.

PMID:
21727913
39.

Necrotic concentrations of cisplatin activate the apoptotic machinery but inhibit effector caspases and interfere with the execution of apoptosis.

Sancho-Martínez SM, Piedrafita FJ, Cannata-Andía JB, López-Novoa JM, López-Hernández FJ.

Toxicol Sci. 2011 Jul;122(1):73-85. doi: 10.1093/toxsci/kfr098. Epub 2011 Apr 28.

PMID:
21527773
40.

The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease.

Pritchett Y, Jemiai Y, Chang Y, Bhan I, Agarwal R, Zoccali C, Wanner C, Lloyd-Jones D, Cannata-Andía JB, Thompson T, Appelbaum E, Audhya P, Andress D, Zhang W, Solomon S, Manning WJ, Thadhani R.

Clin Trials. 2011 Apr;8(2):165-74. doi: 10.1177/1740774511399128.

PMID:
21478328
41.

Vascular calcification in patients with chronic kidney disease: types, clinical impact and pathogenesis.

Román-García P, Rodríguez-García M, Cabezas-Rodríguez I, López-Ongil S, Díaz-López B, Cannata-Andía JB.

Med Princ Pract. 2011;20(3):203-12. doi: 10.1159/000323434. Epub 2011 Mar 29. Review.

42.

Low calcidiol levels and risk of progression of aortic calcification.

Naves-Díaz M, Cabezas-Rodríguez I, Barrio-Vázquez S, Fernández E, Díaz-López JB, Cannata-Andía JB.

Osteoporos Int. 2012 Mar;23(3):1177-82. doi: 10.1007/s00198-011-1550-0. Epub 2011 Feb 10.

PMID:
21308362
43.

Estrogens and bone disease in chronic kidney disease: role of FGF23.

Cannata-Andía JB, Carrillo-López N, Naves-Díaz M.

Curr Opin Nephrol Hypertens. 2010 Jul;19(4):354-8. doi: 10.1097/MNH.0b013e328338f508. Review.

PMID:
20571400
44.

Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.

Naves-Díaz M, Passlick-Deetjen J, Guinsburg A, Marelli C, Fernández-Martín JL, Rodríguez-Puyol D, Cannata-Andía JB.

Nephrol Dial Transplant. 2011 Jun;26(6):1938-47. doi: 10.1093/ndt/gfq304. Epub 2010 May 31.

PMID:
20513773
45.

Differential effects of 17beta-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency.

Naves-Díaz M, Carrillo-López N, Rodríguez-Rodríguez A, Braga S, Fernández-Coto T, Lopez-Novoa JM, López-Hernández F, Cannata-Andía JB.

Menopause. 2010 Jul;17(4):766-71. doi: 10.1097/gme.0b013e3181ce6874.

PMID:
20386345
46.

Lanthanum activates calcium-sensing receptor and enhances sensitivity to calcium.

Carrillo-López N, Fernández-Martín JL, Alvarez-Hernández D, González-Suárez I, Castro-Santos P, Román-García P, López-Novoa JM, Cannata-Andía JB.

Nephrol Dial Transplant. 2010 Sep;25(9):2930-7. doi: 10.1093/ndt/gfq124. Epub 2010 Mar 15.

PMID:
20233740
47.

Parathyroid gland regulation: contribution of the in vivo and in vitro models.

Carrillo-López N, Román-García P, Fernández-Martín JL, Cannata-Andía JB.

Expert Opin Drug Discov. 2010 Mar;5(3):265-75. doi: 10.1517/17460441003615170. Epub 2010 Feb 13.

PMID:
22823022
48.

New therapies: calcimimetics, phosphate binders and vitamin D receptor activators.

Cannata-Andía JB, Rodriguez-García M, Román-García P, Tuñón-le Poultel D, López-Hernández F, Rodríguez-Puyol D.

Pediatr Nephrol. 2010 Apr;25(4):609-16. doi: 10.1007/s00467-010-1462-9. Epub 2010 Feb 12. Review.

PMID:
20151157
49.

Residue 826 in the calcium-sensing receptor is implicated in the response to calcium and to R-568 calcimimetic compound.

Alvarez-Hernández D, González-Suárez I, Fernández-Martín JL, Rodríguez I, Santamaría I, Coto E, Cannata-Andía JB.

Calcif Tissue Int. 2010 Mar;86(3):227-33. doi: 10.1007/s00223-009-9298-7. Epub 2010 Feb 4.

PMID:
20130845
50.

Calcium in chronic kidney disease: myths and realities. Introduction.

Langman CB, Cannata-Andía JB.

Clin J Am Soc Nephrol. 2010 Jan;5 Suppl 1:S1-2. doi: 10.2215/CJN.06140809. No abstract available.

Supplemental Content

Loading ...
Support Center